Credit Suisse’s FibroGen FGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-4,244
Closed -$286K 3141
2023
Q2
$286K Buy
4,244
+1,194
+39% +$80.6K ﹤0.01% 3002
2023
Q1
$1.42M Buy
3,050
+57
+2% +$26.6K ﹤0.01% 2069
2022
Q4
$1.2M Sell
2,993
-82
-3% -$32.8K ﹤0.01% 2207
2022
Q3
$1M Buy
3,075
+524
+21% +$170K ﹤0.01% 2322
2022
Q2
$674K Sell
2,551
-136
-5% -$35.9K ﹤0.01% 2634
2022
Q1
$807K Buy
2,687
+266
+11% +$79.9K ﹤0.01% 2660
2021
Q4
$854K Sell
2,421
-359
-13% -$127K ﹤0.01% 2684
2021
Q3
$710K Sell
2,780
-215
-7% -$54.9K ﹤0.01% 2794
2021
Q2
$1.99M Sell
2,995
-345
-10% -$230K ﹤0.01% 2195
2021
Q1
$2.9M Sell
3,340
-2,986
-47% -$2.59M ﹤0.01% 1918
2020
Q4
$5.87M Buy
6,326
+2,065
+48% +$1.91M ﹤0.01% 1420
2020
Q3
$4.38M Sell
4,261
-22,317
-84% -$22.9M ﹤0.01% 1363
2020
Q2
$26.9M Buy
26,578
+4,640
+21% +$4.7M 0.02% 620
2020
Q1
$19.1M Sell
21,938
-2,415
-10% -$2.1M 0.02% 686
2019
Q4
$26.1M Buy
24,353
+5,024
+26% +$5.39M 0.02% 665
2019
Q3
$17.9M Sell
19,329
-1,337
-6% -$1.24M 0.02% 739
2019
Q2
$23.3M Buy
20,666
+272
+1% +$307K 0.02% 644
2019
Q1
$27.7M Sell
20,394
-2,342
-10% -$3.18M 0.03% 533
2018
Q4
$26.3M Sell
22,736
-643
-3% -$744K 0.03% 521
2018
Q3
$35.5M Sell
23,379
-3,471
-13% -$5.27M 0.03% 478
2018
Q2
$42M Sell
26,850
-7,951
-23% -$12.4M 0.04% 387
2018
Q1
$40.2M Buy
34,801
+31,653
+1,005% +$36.6M 0.04% 426
2017
Q4
$3.73M Sell
3,148
-305
-9% -$361K ﹤0.01% 1625
2017
Q3
$4.64M Buy
3,453
+1,202
+53% +$1.62M ﹤0.01% 1487
2017
Q2
$1.82M Sell
2,251
-3,117
-58% -$2.52M ﹤0.01% 1955
2017
Q1
$3.31M Buy
5,368
+3,406
+174% +$2.1M ﹤0.01% 1674
2016
Q4
$1.05M Sell
1,962
-1,059
-35% -$567K ﹤0.01% 2654
2016
Q3
$1.56M Sell
3,021
-13,786
-82% -$7.14M ﹤0.01% 2273
2016
Q2
$6.9M Buy
16,807
+185
+1% +$75.9K 0.01% 1254
2016
Q1
$8.85M Buy
16,622
+10,348
+165% +$5.51M 0.01% 1062
2015
Q4
$4.78M Buy
6,274
+1,255
+25% +$956K 0.01% 1490
2015
Q3
$2.75M Buy
5,019
+258
+5% +$141K ﹤0.01% 1871
2015
Q2
$2.8M Buy
4,761
+4,384
+1,163% +$2.58M ﹤0.01% 2067
2015
Q1
$296K Buy
+377
New +$296K ﹤0.01% 3601